摘要
目的:探讨糖化血红蛋白水平与脑卒中预后的相关性,指导临床治疗及判断预后。方法:选择我院神经内科住院且病例资料完整的脑卒中患者58例,根据首次监测糖化血红蛋白HbA1c水平分为HbA1c正常组(HbA1c≤6.0%)、HbA1c升高组(HbA1c>6.0%)。结果:脑卒中患者神经功能损伤随HbA1c水平、血糖水平升高而加重。结论:HbA1c水平与脑卒中患者预后有相关性,临床应监测HbA1c水平以指导治疗,判断短期预后。
Objective: To investigate the relativity between the levels of HbA1c and the prognosis of the stroke, guide the clinical treatments and judgement of prognosis. Methods: 58 cases of stroke who were hospitalized in the neurology of our hospital and had intact clinical data were divided into the normal group (HbA1c〈6.0%) and the elevatory group (HbAlc〉 6.0% ) according to the levels of HbA1c monitored for the first time. Results: The levels of the HbAic and BS increased along with the injury of the nerve functions. Conclusion: There are correlations between the levels of HbAlc and the prognosis of the stroke, HbA1c should be used to guide the clinic and judge the prognosis in the future.
出处
《中国医药导报》
CAS
2009年第26期34-35,共2页
China Medical Herald